High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (Multi-Ethnic Study of Atherosclerosis)

Journal of the American College of Cardiology

Volumn 60, Issue 6, 2012, Pages 508-516

  MacKey, Rachel H ^a   Greenland, Philip ^b   Goff Jr , David C ^c   Lloyd Jones, Donald ^b   Sibley, Christopher T ^d   Mora, Samia ^e  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

cardiovascular disease; high density lipoprotein cholesterol; high density lipoprotein particles; lipids; lipoproteins

Indexed keywords

HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HIGH DENSITY LIPOPROTEIN PARTICLE; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN PARTICLE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AGED; ANGINA PECTORIS; ARTERIAL WALL THICKNESS; ARTICLE; BODY MASS; CARDIOMETABOLIC RISK; CARDIOVASCULAR MORTALITY; CAROTID ATHEROSCLEROSIS; COMMON CAROTID ARTERY; DISEASE ASSOCIATION; ETHNICITY; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; INTERNAL CAROTID ARTERY; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS; WAIST CIRCUMFERENCE;

AGED; AGED, 80 AND OVER; CAROTID ARTERY DISEASES; CAROTID ARTERY, COMMON; CAROTID ARTERY, INTERNAL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; COHORT STUDIES; CONTINENTAL POPULATION GROUPS; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; TRIGLYCERIDES; TUNICA INTIMA; TUNICA MEDIA; UNITED STATES;

EID: 84864767131     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.03.060     Document Type: Article

References (39)

1. M. Vergeer, A.G. Holleboom, J.J. Kastelein, J.A. Kuivenhoven The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis? J Lipid Res 51 2010 2058 2073
2. E.M. deGoma, R.L. deGoma, D.J. Rader Beyond high-density lipoprotein cholesterol levels evaluating high-density lipoprotein function as influenced by novel therapeutic approaches J Am Coll Cardiol 51 2008 2199 2211
3. R. Frikke-Schmidt Genetic variation in the ABCA1 gene, HDL cholesterol, and risk of ischemic heart disease in the general population Atherosclerosis 208 2010 305 316
4. T.H. Johannsen, P.R. Kamstrup, R.V. Andersen Hepatic lipase, genetically elevated high-density lipoprotein, and risk of ischemic cardiovascular disease J Clin Endocrinol Metab 94 2009 1264 1273
5. P.J. Barter, M. Caulfield, M. Eriksson Effects of torcetrapib in patients at high risk for coronary events N Engl J Med 357 2007 2109 2122
6. H.N. Ginsberg, M.B. Elam, L.C. Lovato Effects of combination lipid therapy in type 2 diabetes mellitus N Engl J Med 362 2010 1563 1574
7. S.E. Nissen, J.C. Tardif, S.J. Nicholls Effect of torcetrapib on the progression of coronary atherosclerosis N Engl J Med 356 2007 1304 1316
8. R.S. Rosenson, H.B. Brewer Jr., M.J. Chapman HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events Clin Chem 57 2011 392 410
9. W.A. van der Steeg, I. Holme, S.M. Boekholdt High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies J Am Coll Cardiol 51 2008 634 642
10. K. El Harchaoui, B.J. Arsenault, R. Franssen High-density lipoprotein particle size and concentration and coronary risk Ann Intern Med 150 2009 84 93
11. A. Kontush, M.J. Chapman Why is HDL functionally deficient in type 2 diabetes? Curr Diab Rep 8 2008 51 59
12. D. Farbstein, S. Blum, M. Pollak Vitamin E therapy results in a reduction in HDL function in individuals with diabetes and the haptoglobin 2-1 genotype Atherosclerosis 219 2011 240 244
13. J.P. Corsetti, R.T. Gansevoort, C.E. Sparks, R.P. Dullaart Inflammation reduces HDL protection against primary cardiac risk Eur J Clin Invest 40 2010 483 489
14. S. Dodani, R. Kaur, S. Reddy, G.L. Reed, M. Navab, V. George Can dysfunctional HDL explain high coronary artery disease risk in South Asians? Int J Cardiol 129 2008 125 132
15. A.Z. Fan, J.H. Dwyer Sex differences in the relation of HDL cholesterol to progression of carotid intima-media thickness: the Los Angeles Atherosclerosis Study Atherosclerosis 195 2007 e191 e196
16. D.E. Bild, D.A. Bluemke, G.L. Burke Multi-ethnic study of atherosclerosis: objectives and design Am J Epidemiol 156 2002 871 881
17. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, R.C. Turner Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419
18. W.T. Friedewald, R.I. Levy, D.S. Fredrickson Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin Chem 18 1972 499 502
19. E.J. Jeyarajah, W.C. Cromwell, J.D. Otvos Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy Clin Lab Med 26 2006 847 870
20. D.H. O'Leary, J.F. Polak, R.A. Kronmal, T.A. Manolio, G.L. Burke, S.K. Wolfson Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults Cardiovascular Health Study Collaborative Research Group N Engl J Med 340 1999 14 22
21. S. Mora, M. Szklo, J.D. Otvos LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA) Atherosclerosis 192 2007 211 217
22. D.A. Bluemke, R.A. Kronmal, J.A. Lima The relationship of left ventricular mass and geometry to incident cardiovascular events: the MESA (Multi-Ethnic Study of Atherosclerosis) study J Am Coll Cardiol 52 2008 2148 2155
23. J.D. Otvos, S. Mora, I. Shalaurova, P. Greenland, R.H. Mackey, D.C. Goff Jr. Clinical implications of discordance between low-density lipoprotein cholesterol and particle number J Clin Lipidol 5 2011 105 113
24. L.H. Kuller, G. Grandits, J.D. Cohen, J.D. Neaton, R. Prineas Lipoprotein particles, insulin, adiponectin, C-reactive protein and risk of coronary heart disease among men with metabolic syndrome Atherosclerosis 195 2007 122 128
25. D.A. Duprez, L.H. Kuller, R. Tracy Lipoprotein particle subclasses, cardiovascular disease and HIV infection Atherosclerosis 207 2009 524 529
26. J.D. Otvos, D. Collins, D.S. Freedman Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial Circulation 113 2006 1556 1563
27. S. Mora, J.D. Otvos, N. Rifai, R.S. Rosenson, J.E. Buring, P.M. Ridker Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women Circulation 119 2009 931 939
28. J. Hsia, J.D. Otvos, J.E. Rossouw Lipoprotein particle concentrations may explain the absence of coronary protection in the Women's Health Initiative Hormone Trials Arterioscler Thromb Vasc Biol 28 2008 1666 1671
29. A.V. Khera, M. Cuchel, M. Llera-Moya Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis N Engl J Med 364 2011 127 135
30. H.C. Tan, E.S. Tai, D. Sviridov Relationships between cholesterol efflux and high-density lipoprotein particles in patients with type 2 diabetes mellitus J Clin Lipidol 5 2011 467 473
31. I.M. Singh, M.H. Shishehbor, B.J. Ansell High-density lipoprotein as a therapeutic target: a systematic review JAMA 298 2007 786 798
32. K.J. Mukamal, R.H. Mackey, L.H. Kuller Alcohol consumption and lipoprotein subclasses in older adults J Clin Endocrinol Metab 92 2007 2559 2566
33. L.K. Gossett, H.M. Johnson, M.E. Piper, M.C. Fiore, T.B. Baker, J.H. Stein Smoking intensity and lipoprotein abnormalities in active smokers J Clin Lipidol 3 2009 372 378
34. A.D. Gepner, M.E. Piper, H.M. Johnson, M.C. Fiore, T.B. Baker, J.H. Stein Effects of smoking and smoking cessation on lipids and lipoproteins: outcomes from a randomized clinical trial Am Heart J 161 2011 145 151
35. K.K. Pettee, A.M. Kriska, B.D. Johnson The relationship between physical activity and lipoprotein subclasses in postmenopausal women: the influence of hormone therapy Menopause 14 2007 115 122
36. L.H. Kuller, K.K. Pettee Gabriel, L.S. Kinzel The Women on the Move Through Activity and Nutrition (WOMAN) Study: final 48-month results Obesity 20 2012 636 643
37. H. Jafri, A.A. Alsheikh-Ali, P. Mooney, C.D. Kimmelstiel, R.H. Karas, J.T. Kuvin Extended-release niacin reduces LDL particle number without changing total LDL cholesterol in patients with stable CAD J Clin Lipidol 3 2009 45 50
38. N. Rashedi, D. Brennan, J.J. Kastelein, S.E. Nissen, S. Nicholls Impact of cholesteryl ester transfer protein inhibition on nuclear magnetic resonance derived lipoprotein particle parameters (abstr) Atherosclerosis Supplements 12 2011 48
39. R.S. Rosenson, J.D. Otvos, J. Hsia Effects of rosuvastatin and atorvastatin on LDL and HDL particle concentrations in patients with metabolic syndrome: a randomized, double-blind, controlled study Diabetes Care 32 2009 1087 1091